Sunday, March 13, 2022 12:40:33 AM
Recent DRTS News
- Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
- Alpha Tau to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/21/2024 12:45:00 PM
- Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/20/2024 08:01:00 PM
- Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer • GlobeNewswire Inc. • 05/13/2024 12:30:00 PM
- Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow • GlobeNewswire Inc. • 05/06/2024 12:30:00 PM
- Alpha Tau to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit • GlobeNewswire Inc. • 03/25/2024 12:50:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 09:13:56 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 09:05:04 PM
- Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/07/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:32:03 PM
- Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/20/2023 02:16:03 PM
- Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/20/2023 02:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/18/2023 04:09:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/29/2023 01:35:02 PM
- Alpha Tau to Participate in Sidoti Small-Cap Conference • GlobeNewswire Inc. • 11/29/2023 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 01:35:19 PM
- Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer • GlobeNewswire Inc. • 11/28/2023 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2023 11:18:04 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2023 01:35:02 PM
- Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer • GlobeNewswire Inc. • 11/20/2023 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 09:32:05 PM
- Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/16/2023 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 09:18:12 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM